Related Experiment Video
Updated: Jun 12, 2026

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
Published on: November 20, 2018
The role of the lipid bilayer in tau aggregation
Shana Elbaum-Garfinkle1, Trudy Ramlall, Elizabeth Rhoades
1Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.
Abstract:
Tau is a microtubule associated protein whose aggregation is implicated in a number of neurodegenerative diseases. We investigate the mechanism by which anionic lipid vesicles induce aggregation of tau in vitro using K18, a fragment of tau corresponding to the four repeats of the microtubule binding domain. Our results show that aggregation occurs when the amount of K18 bound to the lipid bilayer exceeds a critical surface density. The ratio of protein/lipid at the critical aggregation concentration is pH-dependent, as is the binding affinity. At low pH, where the protein binds with high affinity, the critical surface density is independent both of total lipid concentration as well as the fraction of anionic lipid present in the bilayer. Furthermore, the aggregates consist of both protein and vesicles and bind the beta-sheet specific dye, Thioflavin T, in the manner characteristic of pathological aggregates. Our results suggest that the lipid bilayer facilitates protein-protein interactions both by screening charges on the protein and by increasing the local protein concentration, resulting in rapid aggregation. Because anionic lipids are abundant in cellular membranes, these findings contribute to understanding tau-lipid bilayer interactions that may be relevant to disease pathology.
Insights
Anionic lipid vesicles induce tau protein aggregation, a key factor in neurodegenerative diseases. This aggregation is triggered by exceeding a critical surface density of tau on the lipid bilayer.
Area of Science:
- Biochemistry
- Neuroscience
- Cell Biology
Background:
- Tau protein aggregation is a hallmark of neurodegenerative diseases.
- Understanding the mechanisms driving tau aggregation is crucial for disease pathology insights.
Purpose of the Study:
- To investigate how anionic lipid vesicles induce tau aggregation in vitro.
- To elucidate the role of lipid bilayers in modulating tau protein interactions.
Main Methods:
- Utilized K18, a tau fragment, and anionic lipid vesicles for in vitro aggregation studies.
- Analyzed protein-lipid interactions, binding affinity, and aggregate formation using biophysical techniques.
- Assessed aggregate characteristics using Thioflavin T binding assays.
Main Results:
- Tau aggregation initiated when K18 bound to lipid bilayers exceeded a critical surface density.
- Protein-lipid ratio at aggregation threshold and binding affinity were pH-dependent.
- Aggregates comprised both protein and vesicles, exhibiting pathological characteristics via Thioflavin T binding.
Conclusions:
- Lipid bilayers facilitate tau aggregation by screening protein charges and increasing local protein concentration.
- Abundant anionic lipids in cellular membranes suggest a significant role in tau-lipid interactions relevant to disease.
- Findings contribute to understanding the molecular mechanisms underlying tauopathies.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Asymmetric Lipid Bilayer
Fluid Mosaic Model
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Membrane Fluidity
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is a relatively...
Assembly of the Lipid Bilayer in the ER
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...

